JMIR Publications

ABSTRACT

Healthcare delivery is becoming increasingly digitized, driven by the pursuit of improved access, equity, efficiency, and effectiveness. However, progress does not appear to be equally distributed across therapeutic areas. Oncology is renowned for leading innovation in research and in care; digital pathology, digital radiology, real-world data, next-generation sequencing, patient-reported outcomes, and precision approaches driven by complex data and biomarkers are hallmarks of the field. However, remote patient monitoring, decentralized approaches to care and research, “hospital at home,” and machine learning techniques have yet to be broadly deployed to improve cancer care. In response, the Digital Medicine Society (DiMe) and Moffitt Cancer Center convened a multi-stakeholder roundtable discussion to bring together leading experts in cancer care and digital innovation. This Viewpoint highlights the findings from these discussions, in which experts agreed that digital innovation is lagging in oncology relative to other therapeutic areas. It reports that this lag is most likely attributed to 1) poor articulation of the challenges in cancer care and research best suited to digital solutions, 2) lack of incentives and support, and 3) missing standardized infrastructure to implement digital innovations. It concludes with the necessary actions needed to bring the promise of digitization to cancer care in order to improve lives.